Next Ventures Invests in BranchLab for AI-Driven Healthcare Marketing

Next Ventures has announced a strategic investment in BranchLab to accelerate AI innovation in privacy-focused, precision healthcare marketing, announced in a press release. BranchLab, known for its AI-native solutions, utilizes its Pathwai™ platform to transform non-health data into valuable assets for healthcare marketing, optimizing real-world health outcomes.

The investment aligns with Next Ventures' vision of reshaping healthcare into a proactive, interconnected system. BranchLab's technology enables brands and agencies to design and measure audiences based on outcomes like prescriptions and diagnoses, while maintaining a privacy-first approach. This partnership aims to shift the healthcare system from reactive 'sick care' to proactive patient engagement, ensuring earlier intervention in patients' health journeys.

BranchLab's CEO, Josh Walsh, emphasized the company's commitment to improving public health outcomes through advanced AI methods. The collaboration with Next Ventures is expected to further enhance BranchLab's capabilities in reaching qualified patient audiences and expanding its market presence.